See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Invest-NL is the Dutch national financing and development institution, established in 2020, with a mandate to invest where the market hesitates. It provides patient risk capital—directly in innovative companies and indirectly via investment funds—to accelerate societal transitions across five strategic themes: Agrifood, Biobased & Circular Economy, Deep Tech, Energy, and Life Sciences & Health. The firm targets Dutch startups and scale-ups from early stage through growth, co-investing pari passu with private investors, mobilising additional capital, and resolving financing bottlenecks that prevent breakthrough technologies from reaching scale. As CEO Rinke Zonneveld has stated, 'We are not here for safe bets'—failures and high-risk bets are inherent to the mission of a national impact investor.
Notable quotes
“Wij zijn er niet voor safe bets. Dat is een cultuurding waarop ik blijf hameren binnen onze organisatie. ('We are not here for safe bets. That is a cultural thing I keep hammering on within our organisation.')”
“Invest-NL needs to play an even more prominent role. I believe that the government should be less concerned with subsidies and should be more willing to embark on entrepreneurial ventures with entrepreneurs.”
“To close the innovation gap with America and China somewhat, we in the Netherlands also need to invest substantially more.”
Team
Albertien Greijdanus
Senior Investment Manager
Elisabeth Storm de Grave
Investment Principal
Rinke Zonneveld
CEO
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Nearfield Instruments | Series D | $380m | 2026-06 |
| Axelera AI | Series B | $250m | 2026-02 |
| QuantWare | Series B | $178m | 2026-05 |
| Rift | Series B | $132m | 2026-03 |
| Mosa Meat | Series B | $18m | 2025-12 |
| Fairphone | Series B | $56m | 2023-01 |
| Battolyser Systems | Series A | $33m | 2023-09 |
| Onera Health | Series C | $32m | 2024-01 |
| Lightyear | Growth | $90m | 2022-07 |
| ONWARD Medical | Growth | $48m | 2026-04 |
Frequent co-investors
Fit check
Is Invest-NL a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit